This study investigates advanced metastatic pancreatic cancer. It focuses on using a combination of investigational treatments to evaluate their effects on the condition.
The purpose of this study is to evaluate the effectiveness and safety of the investigational medication in treating advanced metastatic pancreatic cancer.
- Who can participate: Adults aged 18 and older with advanced metastatic pancreatic cancer may participate. Participants must not have received any prior anti-tumor treatment and must meet specific health criteria, including adequate performance status and measurable lesions.
- Study details: Participants will take part in a study evaluating an investigational medication regimen.